Workshop Date and Time

Friday, November 8, 2019, 1:30 – 2:30 pm, Eastern Time

Registrants can listen in live over the phone or online as a webcast.

Listen Now

Topics Covered

  • Overview of Acute Myelogenous Leukemia (AML)
  • Current Treatment Options
  • Transplantation as a Treatment Option for AML
  • New Therapies
  • The Role of Clinical Trials
  • Clinical Trial Updates
  • Symptom, Side Effect & Pain Management Tips
  • Key Questions to Ask Your Health Care Team
  • Quality-of-Life Concerns
  • Questions for Our Panel of Experts

Our Panel of Experts

Farhad Ravandi-Kashani, MD

Janiece and Stephen A. Lasher Professor of Medicine, Chief, Section of Departmental Therapeutics, Department of Leukemia, The University of Texas MD Anderson Cancer Center

Mary-Elizabeth Percival, MD, MS

Assistant Professor, Division of Hematology, University of Washington School of Medicine, Assistant Member, Clinical Research Division, Fred Hutchinson Cancer Research Center, Attending Physician, Seattle Cancer Care Alliance

Carolyn Messner, DSW, OSW-C, FAPOS, FAOSW

Director of Education and Training, CancerCare

Brochure

You can download the brochure for this workshop(pdf)(80.8 KB)

Workshop Date

This workshop was originally recorded on November 08, 2019.

Browse by Diagnosis

Browse by Topic

The information presented in this workshop is provided for your general information only. It is not intended as medical advice and should not be relied upon as a substitute for consultations with qualified health professionals who are aware of your specific situation. We encourage you to take information and questions back to your individual health care provider as a way of creating a dialogue and partnership about your cancer and your treatment.

Back to Top
Terms of Use and Privacy Policy

By using our website, you agree to our recently updated Privacy Policy . Here you can read more about our use of cookies which help us make continuous improvements to our website. Privacy Policy.